Biotechnology: research

115 research items

Journal articles, academic blogs, think-tank reports and papers in this section, newest first. Back to the news.

Nature Biotechnology Han Huang

Programmable functional RNA design with a virtual scientist

Nature Biotechnology, Published online: 19 November 2026; doi:10.1038/s41587-026-03362-3 RhoAgent designs functional RNA molecules by constraining secondary structure, base interactions and functional motifs.

Read at Nature Biotechnology

Nature Biotechnology Yongjian Chen

Author Correction: The global patent landscape of bispecific antibodies: technological innovations and therapeutic applications

Nature Biotechnology, Published online: 17 November 2026; doi:10.1038/s41587-026-03405-9 Author Correction: The global patent landscape of bispecific antibodies: technological innovations and therapeutic applications

Read at Nature Biotechnology

Nature Biotechnology Lingjuan Hong

A CD7-targeted AAV variant enables efficient T and NK cell engineering in vivo

Nature Biotechnology, Published online: 16 November 2026; doi:10.1038/s41587-026-03344-5 Adeno-associated virus vectors targeted to CD7 enable T and NK cell engineering in vivo.

Read at Nature Biotechnology

Nature Biotechnology Thomas Burger

A unified and practical taxonomy for false discovery rate control in omics research

Nature Biotechnology, Published online: 13 November 2026; doi:10.1038/s41587-026-03379-8 False discovery rate (FDR) control is central to omics research, yet the diverse procedures used rely on different assumptions. This Comment proposes a 2 × 2 matrix that helps sequencing-based and mass-spectrometry-based omics researchers choose the appropriate family of FDR procedures, or alternative methods that may be more rigorous, depending on data and study design.

Read at Nature Biotechnology

Nature Biotechnology Sojin Bing

A comprehensive analysis of CBER experience with AAV gene therapy IND submissions

Nature Biotechnology, Published online: 12 November 2026; doi:10.1038/s41587-026-03378-9 An analysis of Investigational New Drug (IND) submissions to the US Food and Drug Administration (FDA) from 1995 to 2025 reveals a rapid growth in adeno-associated virus (AAV) development over three decades and highlights common reasons for regulatory holds that should be considered for successful product development.

Read at Nature Biotechnology

arXiv (research papers) Dingshuo Chen SI

Binding Mode Matters: Hotspot-Aware Drug Discovery via Explorative Preferences

Discovering hit molecules requires not just high binding affinity, but also the identification of diverse binding modes, which are critical for experimental assays. Existing generative approaches have predominantly relied on optimizing a scalar docking score, obscuring the distinct contributions of key binding determinants. To this end, we introduce a paradigm shift by formulating target-based drug design as a multi-objective exploration task, where each objective explicitly…

Read at arXiv (research papers)

Nature Biotechnology

Climate biotechnology

Nature Biotechnology, Published online: 10 November 2026; doi:10.1038/s41587-026-03370-3 Recent patents relating to biotechnological solutions to mitigate or adapt to climate change.

Read at Nature Biotechnology

Nature Biotechnology Dario Ummarino

Dual-layer engineering of herbicide resistance in crops

Nature Biotechnology, Published online: 10 November 2026; doi:10.1038/s41587-026-03391-y Dual-layer engineering of herbicide resistance in crops

Read at Nature Biotechnology

Nature Biotechnology Dario Ummarino

De novo design of proteases

Nature Biotechnology, Published online: 10 November 2026; doi:10.1038/s41587-026-03389-6 De novo design of proteases

Read at Nature Biotechnology

Nature Biotechnology

Biotech news from around the world

Nature Biotechnology, Published online: 10 November 2026; doi:10.1038/s41587-026-03384-x Biotech news from around the world

Read at Nature Biotechnology

Nature Biotechnology

Silence snapped up for $1.3 billion

Nature Biotechnology, Published online: 10 November 2026; doi:10.1038/s41587-026-03393-w Silence snapped up for $1.3 billion

Read at Nature Biotechnology

Nature Biotechnology Dario Ummarino

Searching perturbation dictionaries with RNA fingerprints

Nature Biotechnology, Published online: 10 November 2026; doi:10.1038/s41587-026-03390-z Searching perturbation dictionaries with RNA fingerprints

Read at Nature Biotechnology

Nature Biotechnology

UK Biobank adds immune and brain health layers

Nature Biotechnology, Published online: 10 November 2026; doi:10.1038/s41587-026-03388-7 UK Biobank adds immune and brain health layers

Read at Nature Biotechnology

Nature Biotechnology

China plans ban on biotech exports

Nature Biotechnology, Published online: 10 November 2026; doi:10.1038/s41587-026-03397-6 China plans ban on biotech exports

Read at Nature Biotechnology

Journal articles (OpenAlex) Thomas E. Ichim, Neil H Riordan · Journal of Translational Medicine

Immunological aspects of mesenchymal stem cell therapy for ALS

Neuroinflammation contributes to ALS progression, yet effective immune-modulating therapies remain limited. Despite the enthusiasm regarding stem cell therapy as a means of regeneration, it is interesting that the first FDA approval for mesenchymal stem cells (MSC) was for immune modulation, graft versus host disease (GVHD), not rejuvenation. We focus here on the immunological mechanisms through which MSC, particularly via induction of regulatory T cells, may slow…

Read at Journal articles (OpenAlex)

Journal articles (OpenAlex) Todd W. Pascarella, Jason M. Newman, Jessica Demitor et al. · Frontiers in Chemical Biology

Where should surface plasmon resonance go next? Toward mechanistic drug discovery

Surface plasmon resonance (SPR) has become a central method for quantifying biomolecular interactions through real-time measurements of affinity, association and dissociation rate constants, residence time, and binding capacity. However, these parameters do not necessarily identify the molecular state responsible for biological activity. This Perspective examines how SPR can move beyond binary interaction analysis toward a more mechanistic description of molecular…

Read at Journal articles (OpenAlex)

Journal articles (OpenAlex) Yi Sun, Jiaqi Li, Sisi Yang et al. · Analytical Chemistry

Blocker-Strand Continuity Regulates CRISPR/Cas12a Activity for Dual-Enzyme-Responsive Fluorescence Sensing

Abstract CRISPR/Cas12a is widely used for nucleic acid analysis because it is programmable and provides trans-cleavage-based signal amplification. However, precise control of Cas12a activity remains important for reliable sensing. Here, we examined how blocker continuity affects Cas12a regulation by comparing continuous and split blockers with the same total number of complementary bases. A continuous ssDNA blocker spanning both the spacer and repeat-derived handle regions…

Read at Journal articles (OpenAlex)

Journal articles (OpenAlex) Chentao Zhang, Haozhen Liang, Yizhe Zhang et al. · Genes

CRISPR/Cas9-Mediated Deletion of lpxM and lpxL Reduces Endotoxin Activity in Escherichia coli W3110 Without Compromising Recombinant Protein Production

Background/Objectives: Escherichia coli (E. coli) W3110 is a common host for recombinant protein production. However, lipopolysaccharide (LPS) endotoxin pollution brings extra challenges for downstream purification and safety testing of biotherapeutic proteins. This work set out to build low-endotoxin E. coli mutants by editing lipid A synthesis genes. We further tested their growth profiles, endotoxin levels, and ability to produce recombinant anti-vWF-A1 protein. Methods…

Read at Journal articles (OpenAlex)

Journal articles (OpenAlex) A. V. Lisov, Marina U. Safronova, Oksana V. Belova et al. · BioTech

Xylanases of Streptomyces prunicolor, Streptomyces carpinensis, and Streptomyces venezuelae: Expression, Biochemical Properties and Biotechnological Potential

A study of bacterial xylanases from Streptomyces prunicolor, Streptomyces carpinensis, and Streptomyces venezuelae was conducted. The xylanase-encoding genes were cloned from bacterial genomes. Recombinant producers based on E. coli M15(Rep4) and the pQE-30 vector were obtained, and the expression and purification of the recombinant proteins were carried out. Electrophoretically homogeneous preparations of four xylanases from the GH10 and GH11 families were obtained. The…

Read at Journal articles (OpenAlex)

Journal articles (OpenAlex) Ruyan Xue, Qifei Hu, Rui Sun et al. · Analytical Chemistry

Photo Controlled CRISPR/Cas12a Microdroplets for Amplification-free Nucleic Acid Detection

Abstract Microdroplet platforms provide an amplification-free CRISPR diagnostic method by confining reactions to enhance local target concentration, but spontaneous Cas12a cleavage during droplet generation can generate false-positive signals that compromise quantitative accuracy. To address this, LUCID (Light-Up Cas12a In microDroplets), a photoactivatable CRISPR/Cas12a microdroplet platform was developed for amplification-free, digital nucleic acid detection. The strategy…

Read at Journal articles (OpenAlex)

Journal articles (OpenAlex) Huidong Wang, Yueru Ye, Tong Zhang et al. · Nature Communications

Genome-wide CRISPR screening in Spodoptera frugiperda reveals the determinants of insecticide activation and sensitivity

Insecticide resistance poses a growing threat to global human health and food security. Addressing this challenge requires a comprehensive understanding of the molecular determinants that govern insecticide action and insect sensitivity. However, identifying and functionally validating the specific genes - among the tens of thousands present in a typical insect genome - that contribute to insecticide mode of action and resistance remains a major challenge. Here, we present a…

Read at Journal articles (OpenAlex)

Journal articles (OpenAlex) Danishuddin, Qazi Mohammad Sajid Jamal, Khurshid Ahmad · Pharmaceuticals

From Generative Biology to Evidence-Centric Drug Discovery

Generative and predictive artificial intelligence (AI) is rapidly increasing the number of molecular, structural, cellular, and therapeutic hypotheses that can be explored computationally. Experimental capacity, however, has not expanded at a comparable rate. The result is an evidence bottleneck, in which biological hypotheses are generated faster than they can be experimentally tested, reproduced, and translated. This mismatch is particularly consequential for…

Read at Journal articles (OpenAlex)

Journal articles (OpenAlex) Geofanny Facicilia, Cynthia Retna Sartika, Yuni Elsa Hadisaputri et al. · Cells

CRISPR-Based Engineering of Mesenchymal Stem Cells: Functional Enhancement, Translational Challenges, and Clinical Perspectives

Mesenchymal stem cells (MSCs) are promising platforms for regenerative and immunomodulatory therapies, but their clinical performance is limited by donor heterogeneity, variable potency, and limited persistence. CRISPR-based engineering provides programmable approaches to modify MSC function through genome editing and transcriptional regulation. This review examines CRISPR/Cas9-mediated knockout and knock-in, dCas9-based transcriptional regulation, and emerging base…

Read at Journal articles (OpenAlex)

Journal articles (OpenAlex) Mohammadreza Ashayeri, Sana Rahimian, Hamid Sheikh et al. · Journal of Translational Medicine

CRISPR-engineered mesenchymal stromal cells for cartilage and bone repair

Mesenchymal stromal cells (MSCs) are among the best-characterized cell types in regenerative medicine. They can be readily expanded in culture and differentiated into various tissues and cells, while also exhibiting immunomodulatory characteristics. However, MSCs have limited therapeutic efficacy because they have low survival rates, are heterogeneous, and lose their ability to function after transplantation. New advances in genome editing with CRISPR-Cas9 have opened the…

Read at Journal articles (OpenAlex)

Journal articles (OpenAlex) Tian Gao, Lei He, Yuan Wang et al. · Plants

Biosynthetic Gene Clusters of Astragalus Triterpenoid Saponins: From Genome Discovery to Synthetic Biology and Biomanufacturing Prospects

Astragaloside IV is the best-characterized cycloartane-type triterpenoid saponin and the pharmacopoeial quality marker of Astragali Radix, with documented cardioprotective, antitumor, and immunomodulatory effects. Supply is constrained by long cultivation cycles that vary with production practice, replant disease, and phytochemical variability. Six representative genome assemblies are summarized for the genus, and they show that triterpenoid tailoring genes are partly, but…

Read at Journal articles (OpenAlex)

Journal articles (OpenAlex) Sojin Bing, Takele Argaw, Megha Kaushal et al. · Nature Reviews Drug Discovery

Regulatory lessons from FDA review of approved AAV gene therapies

Read at Journal articles (OpenAlex)

Journal articles (OpenAlex) Junda Liu, Qian Li, Ling Wu et al. · Analytical Chemistry

Guide ssDNA Modulates the Recognition Selectivity of CRISPR-Cas12a for Direct miRNA Detection

Abstract Owing to its robust trans-cleavage activity, CRISPR-Cas12a is a preferred tool for biosensing, yet its native DNA-only recognition limits RNA detection. Herein, we report a simple strategy requiring neither protein mutagenesis nor exogenous factors that enables wild-type Cas12a to directly detect RNA targets. We repurposed the Cas12a recognition unit from a full-length ssDNA into a cooperative assembly of two short ssDNAs. In this assembly, a 10−11 nucleotide primer…

Read at Journal articles (OpenAlex)

Journal articles (OpenAlex) Vaidehi Chandra, Ruben Eduardo Servin Leyva, Catherine Tran · Berkeley Scientific Journal

Transforming Drug Discovery: Teaching LLMs to Speak Chemistry

Read at Journal articles (OpenAlex)

Journal articles (OpenAlex) Shinichi Kinoshita, Yuwei Xie, Haruto Mizukai et al. · Scientific Reports

Efficient generation of non‑mosaic genetically modified marmosets via CRISPR/Cas9 delivery into unfertilized MII oocytes

The common marmoset ( Callithrix jacchus ) is a small nonhuman primate (NHP) with a relatively high reproductive capacity due to its short gestation period and early sexual maturation, making it well suited for producing genetically modified primates. Unlike rodents, marmosets take several years to produce second generation offspring; therefore, analyzing founder-generation animals is especially desirable. However, the frequent occurrence of mosaicism is a major obstacle to…

Read at Journal articles (OpenAlex)

Older stories